Next report date
≈
September 1
Report period
H1 2025
EPS estimate
0.16 USD
Revenue estimate
41.41 B USD
0.32 USD
983.56 M USD
81.55 B USD
1.34 B
About SINOPHARM GROUP CO. LTD.
Sector
Industry
Headquarters
Shanghai
Website
Founded
2003
ISIN
CNE100000FN7
FIGI
BBG000W3LYT8
Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Medical Devices segment consists of the distribution of medical devices in China. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment comprises of the production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.
1.00%
1.17%
1.34%
1.51%
1.68%
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
0.00
11.00 B
22.00 B
33.00 B
44.00 B
Revenue
Net income
Net margin %
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
0.00
11.00 B
22.00 B
33.00 B
44.00 B
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
0.00
11.00 B
22.00 B
33.00 B
44.00 B
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
−7.00 B
0.00
7.00 B
14.00 B
21.00 B
Debt
Free cash flow
Cash & equivalents
No news here
Looks like there's nothing to report right now
The time to wake up the stock of giant Sinopharm is nearSinopharm Group is a profitable Chinese state company with 2 covid-19 vaccines (the first is approved in China) with very strong fundamentals (except debt).
Sinopharms stock seems to be near the end of a many years correction, ready to reverse its declining trend.
Next follows the stocks mid-ter
Health is wealth , agreed ?Some may not agree and that is fine !
Think for a moment. Many of us spent a lot of time working in our career, clocking hours after office hours hoping to gain that year end promotion, score that bonus or simply act out of peer pressure.
Take a minute to read this article I found.
I am of t
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where SHTDF is featured.
Frequently Asked Questions
The current price of SHTDF is 2.15 USD — it has decreased by −12.37% in the past 24 hours. Watch Sinopharm Group Co. Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Sinopharm Group Co. Ltd. stocks are traded under the ticker SHTDF.
SHTDF stock has fallen by −12.37% compared to the previous week, the month change is a −12.37% fall, over the last year Sinopharm Group Co. Ltd. has showed a −17.62% decrease.
We've gathered analysts' opinions on Sinopharm Group Co. Ltd. future price: according to them, SHTDF price has a max estimate of 3.45 USD and a min estimate of 2.11 USD. Watch SHTDF chart and read a more detailed Sinopharm Group Co. Ltd. stock forecast: see what analysts think of Sinopharm Group Co. Ltd. and suggest that you do with its stocks.
SHTDF reached its all-time high on Apr 5, 2018 with the price of 5.64 USD, and its all-time low was 1.80 USD and was reached on Oct 7, 2022. View more price dynamics on SHTDF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SHTDF stock is 14.12% volatile and has beta coefficient of 0.75. Track Sinopharm Group Co. Ltd. stock price on the chart and check out the list of the most volatile stocks — is Sinopharm Group Co. Ltd. there?
Today Sinopharm Group Co. Ltd. has the market capitalization of 7.17 B, it has decreased by −0.61% over the last week.
Yes, you can track Sinopharm Group Co. Ltd. financials in yearly and quarterly reports right on TradingView.
Sinopharm Group Co. Ltd. is going to release the next earnings report on Sep 1, 2025. Keep track of upcoming events with our Earnings Calendar.
SHTDF earnings for the last half-year are 0.15 USD per share, whereas the estimation was 0.19 USD, resulting in a −24.11% surprise. The estimated earnings for the next half-year are 0.16 USD per share. See more details about Sinopharm Group Co. Ltd. earnings.
Sinopharm Group Co. Ltd. revenue for the last half-year amounts to 39.69 B USD, despite the estimated figure of 40.46 B USD. In the next half-year revenue is expected to reach 41.41 B USD.
SHTDF net income for the last half-year is 467.05 M USD, while the previous report showed 513.86 M USD of net income which accounts for −9.11% change. Track more Sinopharm Group Co. Ltd. financial stats to get the full picture.
Yes, SHTDF dividends are paid annually. The last dividend per share was 0.12 USD. As of today, Dividend Yield (TTM)% is 5.36%. Tracking Sinopharm Group Co. Ltd. dividends might help you take more informed decisions.
Sinopharm Group Co. Ltd. dividend yield was 3.37% in 2024, and payout ratio reached 29.35%. The year before the numbers were 4.67% and 29.82% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 12, 2025, the company has 108.22 K employees. See our rating of the largest employees — is Sinopharm Group Co. Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sinopharm Group Co. Ltd. EBITDA is 3.07 B USD, and current EBITDA margin is 3.77%. See more stats in Sinopharm Group Co. Ltd. financial statements.
Like other stocks, SHTDF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sinopharm Group Co. Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sinopharm Group Co. Ltd. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sinopharm Group Co. Ltd. stock shows the strong sell signal. See more of Sinopharm Group Co. Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.